Trial NCT03970694

View at ClinicalTrials.gov 
Org. Study IDs: 2018-FXY-194

Last trial update was posted on 2022-06-08

MeSH Interventions

Capecitabine Oxaliplatin

MeSH Conditions

Colonic Neoplasms

Other Conditions

Colon Cancer

Stopping Reasons

Significant differences in conversion rate as well as R0 resection rate between the two groups.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID